½ÃÀ庸°í¼­
»óǰÄÚµå
1763031

¼¼°èÀÇ ÀǾàǰ ºÎÇüÁ¦ ½ÃÀå(2024-2030³â)

Pharmaceutical Excipients Market, Global, 2024-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Frost & Sullivan | ÆäÀÌÁö Á¤º¸: ¿µ¹® 77 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÀǾàǰÀÇ ¿ëÇØµµ, ¾ÈÁ¤¼º, »ýüÀÌ¿ë·ü, ÄÄÇöóÀ̾𽺸¦ Çâ»ó½ÃŰ´Â ºÎÇüÁ¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ȯÀÚ Á᫐ Á¦Á¦°¡ ±Þ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

Frost & SullivanÀÇ º¸°í¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(MEA) µî ÁÖ¿ä Áö¿ª ½ÃÀåÀ» Áß½ÉÀ¸·Î Àü ¼¼°è ÀǾàǰ ºÎÇüÁ¦ ½ÃÀåÀ» ºÐ¼®ÇÕ´Ï´Ù. °æ±¸¿ë ºÎÇüÁ¦, ÁÖ»çÁ¦ ºÎÇüÁ¦, ±¹¼Ò¿ë ºÎÇüÁ¦, ÈíÀÔ¿ë ºÎÇüÁ¦, ¾È°ú¿ë ºÎÇüÁ¦ µî ´Ù¾çÇÑ ºÎ¹®¿¡ ´ëÇÑ Á¤¼ºÀû, Á¤·®Àû ºÐ¼®À» Á¦°øÇÕ´Ï´Ù. °æ±¸¿ë ºÎÇüÁ¦ ºÎ¹®Àº ´Ù½Ã °æ±¸¿ë °íü¿Í °æ±¸¿ë ¾×ü·Î ¼¼ºÐÈ­µË´Ï´Ù. Àα¸ °í·ÉÈ­¿Í Áúº´ Áõ°¡·Î ÀÎÇØ ¸ðµç Ä¡·á ¿µ¿ª¿¡¼­ ´Ù¾çÇÑ ÀǾàǰ Á¦Á¦¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. °æ±¸ Åõ¿©´Â ºñ¿ë È¿À²¼º°ú ȯÀÚÀÇ ¼øÀÀµµ Çâ»óÀ¸·Î ÀÎÇØ °¡Àå ¼±È£µÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ¿¹Ãø ±â°£ Áß ÈíÀÔ Åõ¿©°¡ °¡Àå Å« ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¿¬±¸´Â ¿¹Ãø ±â°£ Áß »ê¾÷À» Çü¼ºÇÏ´Â ½ÃÀå ¿ªÇп¡ ´ëÇÑ Ã¶ÀúÇÑ ÀÌÇØ¸¦ Á¦°øÇÕ´Ï´Ù. ½ÃÀå ¼ºÀå ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎÀ» ºÐ¼®Çϰí ÀÌ ºÐ¾ßÀÇ º¯È­·Î ÀÎÇÑ ±âȸ¸¦ ½Äº°ÇÏ¿© ½ÃÀå ±â¾÷°ú ÀÌÇØ °ü°èÀÚ°¡ Ȱ¿ëÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. º¸°í¼­ÀÇ ±âÁØ ¿¬µµ´Â 2024³âÀ̸ç, ¿¹Ãø ±â°£Àº 2025-2030³âÀÔ´Ï´Ù.

¸ñÂ÷

¼ºÀå ±âȸ : Á¶»ç ¹üÀ§

  • ºÐ¼® ¹üÀ§
  • Á¶»ç ¹üÀ§¿Í ¼¼ºÐÈ­
  • Á¤ÀÇ

¼ºÀå ȯ°æ : ÀǾàǰ ºÎÇüÁ¦ ½ÃÀå¿¡¼­ÀÇ Æ®·£½ºÆ÷¸ÞÀ̼Ç

  • ¿Ö ¼ºÀåÀÌ ¾î·Á¿öÁö°í Àִ°¡?
  • The Strategic Imperative 8(TM)
  • ÀǾàǰ ºÎÇüÁ¦ ¾÷°è¿¡ ´ëÇÑ Àü·«Àû Çʼö ¿ä°Ç TOP 3ÀÇ ¿µÇâ

ÀǾàǰ ºÎÇüÁ¦ ½ÃÀåÀÇ ¿¡ÄڽýºÅÛ

  • ¹ë·ùüÀÎ
  • °æÀï ȯ°æ
  • ÁÖ¿ä °æÀï»ç
  • °æÀï º¥Ä¡¸¶Å· - °æ±¸Åõ¿©¿ë(°íü)
  • °æÀï º¥Ä¡¸¶Å· - °æ±¸Åõ¿©¿ë(¾×ü)
  • °æÀï º¥Ä¡¸¶Å· - ÁÖ»ç¿ë
  • °æÀï º¥Ä¡¸¶Å· - ±¹¼Ò¿ë
  • °æÀï º¥Ä¡¸¶Å· - ÈíÀÔ¿ë
  • °æÀï º¥Ä¡¸¶Å· - Á¡¾È¿ë
  • ½ÃÀå Ȱµ¿ - Ãâ½Ã, M&A, ÆÄÆ®³Ê½Ê, »ç¾÷ È®´ë(2022-2024³â)

ÀǾàǰ ºÎÇüÁ¦ ½ÃÀåÀÇ ¼ºÀå Á¦³Ê·¹ÀÌÅÍ

  • ¼ºÀå ÁöÇ¥
  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ¿¹Ãø °í·Á»çÇ×
  • ¸ÅÃâ ¿¹Ãø
  • ¸ÅÃâ ¿¹Ãø ºÐ¼®
  • À¯Çüº°, ¸ÅÃâ ¿¹Ãø
  • À¯Çüº°, ¸ÅÃâ ¿¹Ãø ºÐ¼®
  • Áö¿ªº°, ¸ÅÃâ ¿¹Ãø
  • Áö¿ªº°, ¸ÅÃâ ¿¹Ãø ºÐ¼®
  • °¡°Ý µ¿Çâ°ú ¿¹Ãø ºÐ¼®
  • ¸ÅÃâ Á¡À¯À²

¼ºÀå Á¦³Ê·¹ÀÌÅÍ : °æ±¸Åõ¿©¿ë ºÎÇüÁ¦

  • ¼ºÀå ÁöÇ¥
  • ¸ÅÃâ ¿¹Ãø
  • ¸ÅÃâ ¿¹Ãø ºÐ¼®
  • À¯Çüº°, ¸ÅÃâ ¿¹Ãø
  • À¯Çüº°, ¸ÅÃâ ¿¹Ãø - °æ±¸ °íü
  • ¼­ºêŸÀÔº°, ¸ÅÃâ ¿¹Ãø - °áÇÕÁ¦¡¤ÃæÀüÁ¦
  • ¼­ºêŸÀÔº°, ¸ÅÃâ ¿¹Ãø - ÄÚÆÃ
  • ¼­ºêŸÀÔº°, ¸ÅÃâ ¿¹Ãø - ºØ±«Á¦
  • À¯Çüº°, ¸ÅÃâ ¿¹Ãø - °æ±¸ °íü
  • À¯Çüº°, ¸ÅÃâ ¿¹Ãø - °æ±¸ ¾×ü
  • À¯Çüº°, ¿¹Ãø ºÐ¼® - °æ±¸ ¾×ü
  • Áö¿ªº°, ¸ÅÃâ ¿¹Ãø
  • Áö¿ªº°, ¿¹Ãø ºÐ¼®

¼ºÀå Á¦³Ê·¹ÀÌÅÍ : ÁÖ»ç¿ë ºÎÇüÁ¦

  • ¼ºÀå ÁöÇ¥
  • ¸ÅÃâ ¿¹Ãø
  • ¸ÅÃâ ¿¹Ãø ºÐ¼®
  • ¸ÅÃâ ¿¹Ãø
  • À¯Çüº°, ¸ÅÃ⠺м® - ÁÖ»ç¿ë
  • Áö¿ªº°, ¸ÅÃâ ¿¹Ãø
  • Áö¿ªº°, ¿¹Ãø ºÐ¼® - ÁÖ»ç¿ë

¼ºÀå Á¦³Ê·¹ÀÌÅÍ : ±¹¼Ò¿ë ºÎÇüÁ¦

  • ¼ºÀå ÁöÇ¥
  • ¸ÅÃâ ¿¹Ãø
  • ¸ÅÃâ ¿¹Ãø ºÐ¼®
  • ¸ÅÃâ ¿¹Ãø
  • À¯Çüº°, ¿¹Ãø ºÐ¼® - ±¹¼Ò¿ë
  • Áö¿ªº°, ¸ÅÃâ ¿¹Ãø
  • Áö¿ªº°, ¿¹Ãø ºÐ¼® - ±¹¼Ò¿ë

¼ºÀå Á¦³Ê·¹ÀÌÅÍ : ÈíÀÔ¿ë ºÎÇüÁ¦

  • ¼ºÀå ÁöÇ¥
  • ¸ÅÃâ ¿¹Ãø
  • ¸ÅÃâ ¿¹Ãø ºÐ¼®
  • ¸ÅÃâ ¿¹Ãø
  • À¯Çüº°, ¿¹Ãø ºÐ¼® - ÈíÀÔ¿ë
  • Áö¿ªº°, ¸ÅÃâ ¿¹Ãø
  • Áö¿ªº°, ¿¹Ãø ºÐ¼® - ÈíÀÔ¿ë

¼ºÀå Á¦³Ê·¹ÀÌÅÍ : ¾È°ú¿ë ºÎÇüÁ¦

  • ¼ºÀå ÁöÇ¥
  • ¸ÅÃâ ¿¹Ãø
  • ¸ÅÃâ ¿¹Ãø ºÐ¼®
  • ¸ÅÃâ ¿¹Ãø
  • À¯Çüº°, ¿¹Ãø ºÐ¼® - ¾È°ú¿ë
  • Áö¿ªº°, ¸ÅÃâ ¿¹Ãø
  • Áö¿ªº°, ¿¹Ãø ºÐ¼® - ¾È°ú¿ë

ÀǾàǰ ºÎÇüÁ¦ ½ÃÀåÀÇ ¼ºÀå ±âȸ À¯´Ï¹ö½º

  • ¼ºÀå ±âȸ 1 : ½Å±Ô ºÎÇüÁ¦ °³¹ß¿ë µ¶¸³°è ½ÂÀÎ °æ·Î
  • ¼ºÀå ±âȸ 2 : ÈíÀÔ¿ë ¹ÙÀÌ¿À·ÎÁ÷½º
  • ¼ºÀå ±âȸ 3 : ȯÀÚ Á᫐ Á¦Á¦

ºÎ·Ï°ú ´ÙÀ½ ½ºÅÜ

  • ¼ºÀå ±âȸÀÇ ÀÌÁ¡°ú ¿µÇâ
  • ´ÙÀ½ ½ºÅÜ
  • ÀÚ·á ¸®½ºÆ®
  • ¸éÃ¥»çÇ×
KSA

Patient-centric Formulations are Experiencing Transformational Growth Due to Increased Demand for Excipients that Improve Drug Solubility, Stability, Bioavailability, and Compliance

This Frost & Sullivan report analyzes the global pharmaceutical excipients market, with a focus on key regional markets, including North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa (MEA). The report provides both qualitative and quantitative analyses of various segments, including oral dosage excipients, injectable excipients, topical excipients, inhalable excipients, and ophthalmic excipients. The oral dosage excipients segment is further divided into the oral solid excipients and oral liquid excipients. Population aging, combined with a rising prevalence of diseases, is driving demand for diverse drug dosage formulations across all therapeutic areas. The oral route of drug administration is the most preferred due to its cost-effectiveness and better patient compliance. However, the inhalable route is expected to account for the most significant growth during the forecast period. This study offers a thorough understanding of the market dynamics that will shape the industry over the forecast period. It analyzes the factors driving and restraining market growth and identifies opportunities that arise from the changes in this space for market players and stakeholders to leverage. The base year for this report is 2024, while the forecast period extends from 2025 to 2030.

Table of Contents

Growth Opportunities: Research Scope

  • Scope of Analysis
  • Scope and Segmentation
  • Definitions

Growth Environment: Transformation in the Pharmaceutical Excipients Market

  • Why is it Increasingly Difficult to Grow?
  • The Strategic Imperative 8™
  • The Impact of the Top 3 Strategic Imperatives on the Pharmaceutical Excipients Industry

Ecosystem in the Pharmaceutical Excipients Market

  • Value Chain
  • Competitive Environment
  • Key Competitors
  • Competitive Benchmarking-Oral Solid Dosages
  • Competitive Benchmarking-Oral Liquid Dosages
  • Competitive Benchmarking-Injectable
  • Competitive Benchmarking-Topical
  • Competitive Benchmarking-Inhalable
  • Competitive Benchmarking-Ophthalmic
  • Market Activities-Launches, M&As, Partnerships, and Expansions, 2022-2024

Growth Generators in the Pharmaceutical Excipients Market

  • Growth Metrics
  • Growth Drivers
  • Growth Driver Analysis
  • Growth Restraints
  • Growth Restraint Analysis
  • Forecast Considerations
  • Revenue Forecast
  • Revenue Forecast Analysis
  • Revenue Forecast by Type
  • Revenue Forecast Analysis by Type
  • Revenue Forecast by Region
  • Revenue Forecast Analysis by Region
  • Pricing Trends and Forecast Analysis
  • Revenue Share

Growth Generator: Oral Dosage Excipients

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast Analysis
  • Revenue Forecast by Type
  • Revenue Forecast by Type-Oral Solids
  • Revenue Forecast by Sub-type-Binders and Fillers
  • Revenue Forecast by Sub-type-Coatings
  • Revenue Forecast by Sub-type-Disintegrants
  • Forecast Analysis by Type-Oral Solids
  • Revenue Forecast by Type-Oral Liquids
  • Forecast Analysis by Type-Oral Liquids
  • Revenue Forecast by Region
  • Forecast Analysis by Region

Growth Generator: Injectable Excipients

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast Analysis
  • Revenue Forecast
  • Forecast Analysis by Type-Injectables
  • Revenue Forecast by Region
  • Forecast Analysis by Region-Injectables

Growth Generator: Topical Excipient

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast Analysis
  • Revenue Forecast
  • Forecast Analysis by Type-Topical
  • Revenue Forecast by Region
  • Forecast Analysis by Region-Topical

Growth Generator: Inhalable Excipients

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast Analysis
  • Revenue Forecast
  • Forecast Analysis by Type-Inhalable
  • Revenue Forecast by Region
  • Forecast Analysis by Region-Inhalable

Growth Generator: Ophthalmic Excipients

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast Analysis
  • Revenue Forecast
  • Forecast Analysis by Type-Ophthalmic
  • Revenue Forecast by Region
  • Forecast Analysis by Region-Ophthalmic

Growth Opportunity Universe in the Pharmaceutical Excipients Market

  • Growth Opportunity 1: Independent Approval Pathway for the Development of Novel Excipients
  • Growth Opportunity 2: Inhaled Biologics
  • Growth Opportunity 3: Patient-centric Formulations

Appendix & Next Steps

  • Benefits and Impacts of Growth Opportunities
  • Next Steps
  • List of Exhibits
  • Legal Disclaimer
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦